Same Indication

Montelukast vs Osimertinib

Montelukast vs Osimertinib: Overview

This comparison examines the pharmacological differences between Montelukast and Osimertinib.

Mechanism of Action

Montelukast: Selective leukotriene D4 receptor antagonist.

Osimertinib: Third-generation irreversible EGFR TKI targeting T790M resistance mutation and activating mutations.

Pharmacokinetics

Half-life: Montelukast β€” 2.7-5.5 hours; Osimertinib β€” 48 hours.

Chemical Properties

Molecular Formula: Montelukast β€” C35H36ClNO3S; Osimertinib β€” C28H33N7O2.

Molecular Weight: Montelukast β€” 586.1800 g/mol; Osimertinib β€” 499.6050 g/mol.

Type: Montelukast β€” Small molecule; Osimertinib β€” Small molecule.